chrisvoncsefalvay/vaers-outcomes huggingface dataset:
4 days after vaccination #1, a red, raised, swollen rash, appeared  on my chest  (over the manubrium ). It was oval shaped , 3 inches X 2 inches.   The rash itself, disappeared within 3 days, but the swelling has remained for 6 weeks.  After shot #2, the  swelling seemed unaffected, but a pink itchy rash did develop on my bicep (left arm).  This disappeared, but tends to temporarily resurface after hot showers.  The chest swelling still remains.  I had telemedicine visit with the  Dr who suggests I see a surgeon (seriously??)
(L) arm warm, red and firm. (L) arm sore with movement. Pt brought into clinic on 2-19-10 by mom. Mom states symptoms improving at this time.
Throbbing pain, swelling, and redness at injection site Headache Fatigue Muscle Aches Chills
This spontaneous report as receive from a Registered Nurse refers to unspecified patients of unknown age and gender. Medical history and concurrent conditions were not provided. Since 02-FEB-2015, unspecified patients were vaccinated with a dose of improperly stored RECOMBIVAX HB (dose, route, lot number and expiry date were not reported). No adverse effects were reported. There was no concomitant medication provided. This is one of several reports received from the same reporter. Additional information has been requested.
Day one- almost immediately after injection I felt intensely dizzy/vertigo. My body went cold and I couldn't warm up all afternoon. I developed mild shaking from the coldness. It took me hours to warm up. Several hours later, my brain went into "fog" that made me feel cognitively slow. I couldn't think well. Later that evening, I felt very nauseous all night. Day two- dizzy spells, extremely nauseous and very fatigued and short or breath. Day three- dizziness mostly went away, some waves of nausea, pain in the back of my lungs, felt out of breath.  Better by the third day but still feel pain in lungs and some uneasiness in chest/lungs.
Within a couple of days (don't recall exactly) my right hand began to cramp in the palm, between 3rd and 4th fingers (counting thumb as #1). Pain was intense and radiated up into those 2 fingers. continued for months, and still happens occasionally. Sought X-ray and Occupational Therapy for it. much diminished after a couple of months, and improved with OT exercises.   Also began to experience light headaches in the week after the first vaccine, which increased after the second dose on April 9. Continue to have light headaches 2-3 times a week lasting for several hours. Headaches were rare my entire life up til first vaccine.
Fever of 101.4 F, migraine headache. Treated with sleep rest and ibuprofen and hydration of fluids.  17 hours from initial symptoms, fever broke. Temperature normal at 98.6 twelve hours after initial symptoms.
Information has been received from a health professional concerning a 4 year old male with rhinitis allergic and asthma and a history of otitis media who on 22-MAR-2005 was vaccinated with VARIVAX (Oka/Merck) (lot# 647245/0898N) and MMR II. Concomitant therapy included HIBOR and DTAP-IPV. On 05-MAR-2008 the patient developed zoster in right arm and otitis media. The patient was placed on therapy with Acyclovir and VALDREX, 500 mg, three times a day for the treatment of zoster. It was unknown if the patient had recovered from zoster and otitis media. Additional information is not expected.
RA flare started the morning after I received the vaccine.  I had been in remission for a while but the day after I received the vaccine I noticed a lot of pain in several joints especially, my back, right elbow and both hands a fingers.  I also noticed a lot of fatigue which usually accompanies my RA flares.  I will be seeing my Ruematologist on Monday, April  12, 2021 to discuss what to do to get the flare under control.
Fever and seizure resulting in hospitalization; Fever and seizure resulting in hospitalization; Fever and seizure resulting in hospitalization; This is a spontaneous report received from a contactable reporter(s) (Physician).  A 10 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 30Dec2021 (Lot number: FFF8839) at the age of 10 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Hunter syndrome" (unspecified if ongoing); "OSA" (unspecified if ongoing); "Mitral and Aortic regurgitation" (unspecified if ongoing); "Mitral and Aortic regurgitation" (unspecified if ongoing); "Constipation" (unspecified if ongoing); "B/L carpal tunnel syndrome" (unspecified if ongoing); "seizures" (unspecified if ongoing); "global developmental delay" (unspecified if ongoing); "Alcohol (topical)" (unspecified if ongoing), notes: known allergies: Alcohol (topical). Concomitant medication(s) included: DIVALPROEX SODIUM; OXCARBAZEPINE; TYLENOL; LARONIDASE. Past drug history included: Benzodiazepines, reaction(s): "Allergy: Benzodiazepines", notes: known allergies: Benzodiazepines; Amoxicillin, reaction(s): "Allergy: Amoxicillin", notes: known allergies: Amoxicillin; Diphenhydramine-zinc acetate, reaction(s): "Allergy: Diphenhydramine-Zinc Acetate", notes: known allergies: Diphenhydramine-Zinc Acetate; Benadryl, reaction(s): "Allergy: Benadryl", notes: known allergies: Benadryl; Camphor, reaction(s): "Allergy: Camphor", notes: known allergies: Camphor. The following information was reported: SEIZURE (hospitalization, medically significant), CONDITION AGGRAVATED (hospitalization, medically significant), PYREXIA (hospitalization) all with onset 31Dec2021, outcome "recovered" and all described as "Fever and seizure resulting in hospitalization". The patient was hospitalized for condition aggravated, pyrexia (hospitalization duration: 2 day(s)); the patient was hospitalized for seizure (hospitalization duration: 2 day(s)). The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (31Dec2021) negative, notes: Nasal Swab. Therapeutic measures were taken as a result of seizure, condition aggravated, pyrexia. Additional Information: Keppra was received as treatment for the adverse event. Prior to vaccination, patient was not diagnosed with COVID-19, Since the vaccination, patient has not been tested for COVID-19. Device Date was 25Feb2022  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the information available, the causal relationship between the reported events and suspect drug BNT162B2 cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate
received the 1 dose / on 10/22/2020 / 1, 6-month doses were not administered yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 42-year-old female patient who received HBV (Engerix B) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Engerix B (received 1st dose on 22nd October 2020, batch number P4DJ5, expiry date 15th December 2022).   On an unknown date, the patient received the 2nd dose of Engerix B and Engerix B Pre-Filled Syringe Device. On an unknown date, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not received 2nd dose, which led to incomplete course of vaccination. The vaccine administration facility details were reported for 1st dose. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021164837:Same reporter
Tdap one-time booster administered for patient aged 19-64 as of 4/29/10. Per Allergy specialist, pt experienced immediate itch, then 3 days later persistent erythema, which persisted another week. Had reaction to tetanus booster, persistent swelling/erythema and some itch at injection site. Likely had mild immediate and then delayed hypersensitivity to either toxoid or components/preservative. Would just monitor ab level in 10 years and if protective, don't repeat. If imperative, could do formal skin testing in future.
I had a red rash all over my body.  Just touching my skin, I develop a rash in that shot.  I have had this ever since the Dec 18th.  I went to the doctor about this.  They just prescript me medicine for it.
Systemic: Fainting / Unresponsive-Mild, Additional Details: pt fainted after few minutes of vaccine administration, afraid of needle ,very nurvous, said he hadnt had vaccines since high school. confirmed that hw was fine, 911 called, paramedic asked question he answered all question correctly, aware of place time and date and day. did not go with paramedic waited for 30 minutes and left confirming he was doing fine.
This spontaneous report was received from a registered nurse refers to unspecified patients of unkonwn demographics. No medical history was reported. On an unknown date, unspecified number of patients were vaccinated with ROTATEQ (dose, route and frequency unspecified) which was improperly stored since 01-FEB-2014. No concomitant medications were reported. Nurse did not have any patient specific information. No adverse effects were reported. No further information was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Severe hives on torso ares staring on 11/17.  Heat aggravates condition.  Cold showers alleviate symptom.  Over the course of the last 3 weeks, severity and frequency have both decreased.  Last episode (11/16) was triggered by use of hot tub.  If I remain in cold room, mostly normal with minimal discomfort.
Pt had trouble breathing 3 hrs after injection. She used her Albuterol inhaler. She had chest tightness. She also had swelling in her (R) foot making it difficult to walk.
So tired could hardly drive home, very sore uvula for 3 hours, chills, slight fever, horrible migraine, swollen bloodshot eyes, swollen left arm from flu vaccine, both sore but left more so, black stool in morning. Completely exhausted.. three hours sleep.
patients under 18 have been vaccinated; A spontaneous report was received from a pharmacist concerning a patient of unknown age and unknown gender who received Moderna's COVID-19 vaccine and patients under 18 have been vaccinated.  The patient's medical history was not provided.  Concomitant product use was unknown by the reporter.     Prior to the onset of symptoms, the patient received their first of two planned doses of mRNA-1273 (Lot number was unknown) intramuscularly for prophylaxis of COVID-19 infection. Question about any efficacy in patients under 18. Some patients under 18 have been vaccinated, should you wait until 18 to give second dose? Agent called back reporter who stated that patients under the age of 18 have been administered the vaccine. Reporter requested response to be sent to email provided. The reporter who stated that patients under the age of 18 have been administered the vaccine but he did not have patient identifiers or details at the time agent called. He stated that he can obtain the information if needed. He reported that he has already submitted the AE  to VAERS.  He provided consent to contact him.   Action taken with mRNA-1273 in response to the event(s) was not provided.   The outcome of the event was considered to be resolved.; Reporter's Comments: This case concerns a patient of unknown gender and age who received their first of two planned doses of mRNA-1273 (Lot unknown), reporting Product administered to patient of inappropriate age without any associated adverse events.
Not sure the lot number as typed above I typed in the RX #, I started feeling sore in left arm, my fingers and whole body was sore and felt nauseated the evening of the vaccine and all the next day. Also was weak and still sore, also cold, but no fever. I took TYLENOL and used warm pack on neck, back and just slept. The feeling I had was like I had the flu. By the next evening I was feeling better, although my arm still hurt for at least a week after the shot. I just didn't realize that I would feel this way after a shot, I expected my arm to hurt just like the influenza shot but not the feeling like I had the flu.
Patient had a syncopal episode approximately 5 minutes after receiving COVID 19 vaccine.  Patient was immediately placed on gurney.  Syncopal episode lasted approximately 10 seconds. Patient was under medical supervision the entire time and did not hit his head. Initial vitals signs were: BP 110/70, pulse 55, O2 100%.  paramedics did arrive on scene and evaluate the patient. Patient felt much better and refused transport to ER. Patient signed out AMA with paramedics. Note:  Patient admitted to history of syncopal episodes in the past during previous blood draws and vaccine administrations.
swollen lymph nodes; didn't feel good; This is a spontaneous report received from contactable reporter(s) (Other HCP).  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunisation series complete but manufacturer unknown), for COVID-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious), outcome "unknown", described as "swollen lymph nodes"; MALAISE (non-serious), outcome "unknown", described as "didn't feel good".  Additional information: On 25Oct2022, it was reported that a patient started treatment on an unspecified date with Pfizer BioNTech COVID-19 Vaccine at a booster dose for COVID-19 immunization. It was reported the patient had a reaction to the Pfizer booster. The individual reported that she had swollen lymph nodes that lasted for a little while, but it was not severe and also reported that she didn't feel good but that was normal with a booster.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Immun given early afternoon-febrile by early evening; tempra given @ 9PM 1NOV91 pt crying @ 4AM mom attempted to feed but pt feel asleep; awake again @ 445AM very hot, had sz; Taken to ER still febrile seen by MD felt was febrile sz
Weakness, fatigue, Resp SOB, wheezing, chest pain, palpitations, nausea, headache, dizziness,  low blood pressure.
Adverse Events: Within one minute of receiving the injection: -paresthesia occurred in right arm, and then across chest -accelerated heart rate  Within 10 minutes of receiving injection: -Brain fog -Numbness in limbs -Tinnitus in left ear -Difficulty breathing -Dizziness and weakness -Vision blurred  Treatment: Was immediately escorted to have Dr. and Nurses monitor myself for the next hour. Was checked for any signs of rashes - none were immediately seen Vitals were checked after 20 minutes of receiving injection: (Heart rate, temperature, blood O2 levels) - heart rate was slightly elevated; yet all appeared normal Additionally, I informed Medical staff that it appeared I might have also had a panic attack right after the injection; yet some of the adverse reactions were listed on the Jansen Vaccine information PDF, and are not associated with panic attacks. -Was given glucose to normalize blood sugar levels, and Maylox for GERD symptoms. -Condition began to improve; yet severe dizziness, numbness/tingling of limbs persisted for the next 48 hours, intermittently. -72 Hours after injection, felt tightness in chest, intermittently
2/24 rash/itching arms/trunk without burning, 2/25 Benadryl 50mg 1:15AM, 8:20PM Benadryl 20mg PO STAT
1) Started severe palpitation within minutes  2) It followed by severe dizziness and visual haziness 3) After doctors made me lying down on the bed, started feeling better
His right foot swelled up; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 76-year-old male patient received BNT162b2 (BNT162B2), on 25Mar2021 as dose 1, single (Lot number: EM9809) at the age of 76 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PERIPHERAL SWELLING (non-serious) with onset Mar2021, outcome "unknown", described as "His right foot swelled up".  Additional information: Patient and his wife are on the line together. Wife said he had a reaction to the serum on 25Mar2021. Had adverse reactions to the first COVID shot. His right foot swelled up and he couldn't put pressure on it. Swelling started about a day after. It was not right away. Couldn't put shoes on or anything. After the shots, they did call and tell Pfizer about the feet swelling up and couldn't put shoes on. Need help to pay for some of these bills. Shocking that the vaccine didn't do what it was supposed to do. The patient received Prior Vaccinations (within 4 weeks) prior to the first administration date of the suspect vaccine was reported as none. The patients Concomitant Drugs, Medical History (including any illness at time of vaccination) and Family Medical History Relevant to Adverse Events (AEs) was reported as not provided. Specific Relevant Test: For Thromboembolic events with Thrombocytopenia and Autopsy information was reported as not applicable.
lump the size of a quarter / a non-tender lump; redness; some swelling; This case was reported by a other health professional via call center representative and described the occurrence of injection site lump in a 11-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA197A, expiry date unknown) for prophylaxis.   On 1st July 2020, the patient received the 1st dose of Menveo (intramuscular). On 20th July 2020, 19 days after receiving Menveo, the patient experienced injection site lump, injection site erythema and injection site swelling. On 1st September 2020, the outcome of the injection site lump, injection site erythema and injection site swelling were recovered/resolved.   It was unknown if the reporter considered the injection site lump, injection site erythema and injection site swelling to be related to Menveo.  Additional details were provided as follows: The patient received Menveo and had lump the size of a quarter, that was a non-tender lump, with redness and some swelling.  The patient had not contacted again HCP, so HCP thinks patient had recovered from the lump.  The exact dates of onset could not provide but an estimate was given by reporter. The reporter consented to follow up. The HCP mentioned Menveo was given subcutaneously but then said that it was intramuscular administration. This case linked with US2020176182, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020176182:same reporter
Patient broke out in full body hives.  Given Benadryl.  No airway compromise.  Hives resolved in 72 hours.
I reported my adverse event to my doctor on 09/08/2021: "I had Covid Vaccine (Moderna) 1st shot on 6/7/21 and 2nd shot on 7/6/21. After the 2nd shot, I have had left shoulder nerve pain especially when I rotate my arm backward and upward such as taking on or off clothes. I read some side effects are normal, so I just applied patches and exercised my arm. I never had nerve pain except my teeth before, so I thought it's muscle pain and would go away. I mostly feel fatigue, but once in a while, I could not move for 5~10 seconds due to extreme pain on my left shoulder. "  I exercised my arm, shoulder, and heart muscle by stretching, pressing, and massaging even though it was often very painful. The symptom gets better, but I still feel nerve pain over the areas.
No adverse event.  Pt. had previously received the Moderna bivalent vaccine on 12/7/22 and is not immunocompromised thus did not need to receive the second bivalent dose.
Kept feeling chest pains, some days worse than others. Wasn't until at work felt like having heart attack in Sept that my supervisor and director of operations took me to hospital. Sept 13th ran all kinds of tests. B-TYPE NATRIURETIC PEPTIDE, LIPASE, COMPREHENSIVE METABOLIC PANEL, TROPONIN I, URINALYSIS, everything looked good, kept saying healthy, then Sept 20th STRESS TEST WITH MYOCARDIAL PERFUSION, NM HEART PERFUSION SPECT STRESS AND REST,  TRANSTHORACIC ECHO (TTE) COMPLETE, still was told healthy. It wasn't until Oct 13th my Cardiologist asked when I had my vaccination did he order the next test CBC W/ AUTO DIFFERENTIAL, C-REACTIVE PROTEIN, CBC WITH DIFFERENTIAL. With the C-REACTIVE PROTEINS that high couple medications for inflammation stating Pericarditis. Colchicine was one of the meds.   Sept 13th . B-TYPE NATRIURETIC PEPTIDE, LIPASE, COMPREHENSIVE METABOLIC PANEL, TROPONIN I, URINALYSIS   Sept 20th STRESS TEST WITH MYOCARDIAL PERFUSION, NM HEART PERFUSION SPECT STRESS AND REST,  TRANSTHORACIC ECHO (TTE) COMPLETE,  Oct 13th my Cardiologist asked when I had my vaccination did he order the next test CBC W/ AUTO DIFFERENTIAL, C-REACTIVE PROTEIN, CBC WITH DIFFERENTIAL. With the C-REACTIVE PROTEINS that high he put me on Colchicine.
he died of a brain hemorrhage after spending two weeks in the hospital; The same condition severe thrombocytopenia caused his death; This is a spontaneous report received from non-contactable reporter (Consumer or other non HCP).  A male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) (Batch/Lot number: unknown) as dose number unknown, single for COVID-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CEREBRAL HAEMORRHAGE (death, hospitalization, medically significant), outcome "fatal", described as "he died of a brain hemorrhage after spending two weeks in the hospital"; THROMBOCYTOPENIA (death, medically significant), outcome "fatal", described as "The same condition severe thrombocytopenia caused his death". The patient was hospitalized for cerebral haemorrhage (hospitalization duration: 14 days). Therapeutic measures were taken as a result of thrombocytopenia. The patient date of death was unknown. The reported cause of death was brain hemorrhage, severe thrombocytopenia. It was unknown if an autopsy was performed. Clinical course: "The same condition severe thrombocytopenia caused his death, whose symptoms appeared three days after receiving the Pfizer-BioNTech vaccine. Treatments failed to restore his platelets and he died of a brain hemorrhage after spending two weeks in the hospital."   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected. ; Reported Cause(s) of Death: severe thrombocytopenia; brain hemorrhage